Differential drug resistance acquisition to doxorubicin and paclitaxel in breast cancer cells

被引：0
|
作者：
Feifei Xu
Fengliang Wang
Ting Yang
Yuan Sheng
Ting Zhong
Yun Chen
机构：
[1] Nanjing Medical University,School of Pharmacy
[2] Nanjing Maternity and Child Health Care Hospital,undefined
来源：
Cancer Cell International | / 14卷
关键词：
Multi-drug Resistance Acquisition (MDR); P-glycoprotein (P-gp); Drug-specific; Doxorubicin (DOX); Paclitaxel (PTX);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Paclitaxel resistance and nucleostemin upregulation in metastatic mouse breast cancer cells
    Rezapour, Naeemeh
    Kamalabadi-Farahani, Mohammad
    Atashi, Amir
    Zarrinpour, Vajiheh
    MINERVA BIOTECHNOLOGY AND BIOMOLECULAR RESEARCH, 2023, 35 (01): : 16 - 21
  • [32] Downregulation of HuR as a new mechanism of doxorubicin resistance in breast cancer cells
    Elisa Latorre
    Toma Tebaldi
    Gabriella Viero
    Antonino Maria Spartà
    Alessandro Quattrone
    Alessandro Provenzani
    Molecular Cancer, 11
  • [33] Downregulation of HuR as a new mechanism of doxorubicin resistance in breast cancer cells
    Latorre, Elisa
    Tebaldi, Toma
    Viero, Gabriella
    Sparta, Antonino Maria
    Quattrone, Alessandro
    Provenzani, Alessandro
    MOLECULAR CANCER, 2012, 11
  • [34] Doxorubicin resistance in breast cancer cells is mediated by extracellular matrix proteins
    Lovitt, Carrie J.
    Shelper, Todd B.
    Avery, Vicky M.
    BMC CANCER, 2018, 18
  • [35] Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin
    Kovalchuk, Olga
    Filkowski, Jody
    Meservy, James
    IInytskyy, Yaroslav
    Tryndyak, Volodymyr P.
    Chekhun, Vasyl' F.
    Pogribny, Igor P.
    MOLECULAR CANCER THERAPEUTICS, 2008, 7 (07) : 2152 - 2159
  • [36] Doxorubicin resistance in breast cancer cells is mediated by extracellular matrix proteins
    Carrie J. Lovitt
    Todd B. Shelper
    Vicky M. Avery
    BMC Cancer, 18
  • [37] Micro- and Nanosecond Pulses Used in Doxorubicin Electrochemotherapy in Human Breast and Colon Cancer Cells with Drug Resistance
    Rembialkowska, Nina
    Novickij, Vitalij
    Baczynska, Dagmara
    Dubinska-Magiera, Magda
    Saczko, Jolanta
    Rudno-Rudzinska, Julia
    Maciejewska, Magdalena
    Kulbacka, Julita
    MOLECULES, 2022, 27 (07):
  • [38] Preferential potentiation of paclitaxel and doxorubicin cytotoxicity in drug-resistant breast tumor cells by tesmilifene.
    Hembruff, Stacey L.
    Villeneuve, David J.
    Parissenti, Amadeo M.
    CANCER RESEARCH, 2006, 66 (08)
  • [39] A-770041 reverses paclitaxel and doxorubicin resistance in osteosarcoma cells
    Zhenfeng Duan
    Jianming Zhang
    Shunan Ye
    Jacson Shen
    Edwin Choy
    Gregory Cote
    David Harmon
    Henry Mankin
    Yingqi Hua
    Yu Zhang
    Nathanael S Gray
    Francis J Hornicek
    BMC Cancer, 14
  • [40] A-770041 reverses paclitaxel and doxorubicin resistance in osteosarcoma cells
    Duan, Zhenfeng
    Zhang, Jianming
    Ye, Shunan
    Shen, Jacson
    Choy, Edwin
    Cote, Gregory
    Harmon, David
    Mankin, Henry
    Hua, Yingqi
    Zhang, Yu
    Gray, Nathanael S.
    Hornicek, Francis J.
    BMC CANCER, 2014, 14
12345